Skip to content
Update on Anticoagulation in COVID-19 episode artwork

Apr 2, 2021 59 min

Update on Anticoagulation in COVID-19

from CHEST Pulse Hosted by American College of Chest Physicians

Patients with COVID-19 have an increased risk of venous thromboembolism (VTE), but the best strategy for the prevention and care of VTE remains elusive. Observational studies have suggested that empiric full anticoagulation in patients with COVID-19 is ineffective or indeed harmful. Recently, however, multiple large platform trials (ACTIV-4a, ATTACC, and REMAP-CAP) have provided surprising new evidence in favor of full anticoagulation in selected populations. In this episode, our panel of experts review the newest data and provide insights on how we can best care for patients in this next phase of the pandemic. (Originally recorded April 1, 2021) Moderator: Jean M. Elwing, MD, FCCP. Panelists: Sandeep Sahay, MD; Dana Kay, DO; Parth Rali, MD; and Vijay Balasubramanian, MD. For more tools to help in the fight against COVID-19, visit CHEST’s COVID-19 Resource Center at chestnet.org/COVID19.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Update on Anticoagulation in COVID-19

0:00 59:21

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of CHEST Pulse?

This episode is 59 minutes long.

When was this CHEST Pulse episode published?

This episode was published on April 2, 2021.

Can I download this CHEST Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.